-+ 0.00%
-+ 0.00%
-+ 0.00%

CytoSorbents Regains Nasdaq Compliance

Benzinga·09/23/2026 11:03:26
语音播报

CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement of $1.00 per share.